 | • レポートコード：MRC23Q36053 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のフィラリア症治療市場について調査・分析し、世界のフィラリア症治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（スプレー薬、服用薬、その他）、用途別セグメント分析（動物病院、動物病院、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Boehringer Ingelheim、Wellmark International, Inc、HEARTGARD Plus、Merck Animal Health (Merck & Co., Inc.)、Pfizer Inc、Bayer AG、Mylan N.V、Ceva Sante Animale S.A、PetCareRx、Ecto Development Corporationなどが含まれています。世界のフィラリア症治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、フィラリア症治療市場規模を推定する際に考慮しました。本レポートは、フィラリア症治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、フィラリア症治療に関するビジネス上の意思決定に役立てることを目的としています。 ・フィラリア症治療市場の概要 - フィラリア症治療のタイプ別セグメント - 世界のフィラリア症治療市場規模：タイプ別分析（スプレー薬、服用薬、その他） - フィラリア症治療の用途別セグメント - 世界のフィラリア症治療市場規模：用途別分析（動物病院、動物病院、その他） - 世界のフィラリア症治療市場規模予測（2018年-2029年） ・フィラリア症治療市場の成長トレンド - フィラリア症治療の地域別市場規模（2018年-2029年） - フィラリア症治療市場ダイナミクス - フィラリア症治療の業界動向 - フィラリア症治療市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：スプレー薬、服用薬、その他 - 世界のフィラリア症治療のタイプ別市場規模（2018年-2023年） - 世界のフィラリア症治療のタイプ別市場規模（2024年-2029年） ・用途別セグメント：動物病院、動物病院、その他 - 世界のフィラリア症治療の用途別市場規模（2018年-2023年） - 世界のフィラリア症治療の用途別市場規模（2024年-2029年） ・フィラリア症治療の地域別市場規模 - 北米のフィラリア症治療市場規模（2018年-2029年） - アメリカのフィラリア症治療市場規模（2018年-2029年） - ヨーロッパのフィラリア症治療市場規模（2018年-2029年） - アジア太平洋のフィラリア症治療市場規模（2018年-2029年） - 中国のフィラリア症治療市場規模（2018年-2029年） - 日本のフィラリア症治療市場規模（2018年-2029年） - 韓国のフィラリア症治療市場規模（2018年-2029年） - インドのフィラリア症治療市場規模（2018年-2029年） - オーストラリアのフィラリア症治療市場規模（2018年-2029年） - 中南米のフィラリア症治療市場規模（2018年-2029年） - 中東・アフリカのフィラリア症治療市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Boehringer Ingelheim、Wellmark International, Inc、HEARTGARD Plus、Merck Animal Health (Merck & Co., Inc.)、Pfizer Inc、Bayer AG、Mylan N.V、Ceva Sante Animale S.A、PetCareRx、Ecto Development Corporation ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Heartworm Disease Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Heartworm Disease Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Heartworm Disease Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Heartworm Disease Treatment in Animal Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Heartworm Disease Treatment include Boehringer Ingelheim, Wellmark International, Inc, HEARTGARD Plus, Merck Animal Health (Merck & Co., Inc.), Pfizer Inc, Bayer AG, Mylan N.V, Ceva Sante Animale S.A and PetCareRx, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heartworm Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heartworm Disease Treatment.
The Heartworm Disease Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Heartworm Disease Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heartworm Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Boehringer Ingelheim
Wellmark International, Inc
HEARTGARD Plus
Merck Animal Health (Merck & Co., Inc.)
Pfizer Inc
Bayer AG
Mylan N.V
Ceva Sante Animale S.A
PetCareRx
Ecto Development Corporation
Segment by Type
Spray Medicine
Take Medicine
Others
Segment by Application
Animal Hospital
Veterinary Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Heartworm Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Heartworm Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Spray Medicine
1.2.3 Take Medicine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Heartworm Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Animal Hospital
1.3.3 Veterinary Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Heartworm Disease Treatment Market Perspective (2018-2029)
2.2 Heartworm Disease Treatment Growth Trends by Region
2.2.1 Global Heartworm Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Heartworm Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Heartworm Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Heartworm Disease Treatment Market Dynamics
2.3.1 Heartworm Disease Treatment Industry Trends
2.3.2 Heartworm Disease Treatment Market Drivers
2.3.3 Heartworm Disease Treatment Market Challenges
2.3.4 Heartworm Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Heartworm Disease Treatment Players by Revenue
3.1.1 Global Top Heartworm Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Heartworm Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Heartworm Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Heartworm Disease Treatment Revenue
3.4 Global Heartworm Disease Treatment Market Concentration Ratio
3.4.1 Global Heartworm Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Heartworm Disease Treatment Revenue in 2022
3.5 Heartworm Disease Treatment Key Players Head office and Area Served
3.6 Key Players Heartworm Disease Treatment Product Solution and Service
3.7 Date of Enter into Heartworm Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Heartworm Disease Treatment Breakdown Data by Type
4.1 Global Heartworm Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Heartworm Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Heartworm Disease Treatment Breakdown Data by Application
5.1 Global Heartworm Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Heartworm Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Heartworm Disease Treatment Market Size (2018-2029)
6.2 North America Heartworm Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Heartworm Disease Treatment Market Size by Country (2018-2023)
6.4 North America Heartworm Disease Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Heartworm Disease Treatment Market Size (2018-2029)
7.2 Europe Heartworm Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Heartworm Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Heartworm Disease Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Heartworm Disease Treatment Market Size (2018-2029)
8.2 Asia-Pacific Heartworm Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Heartworm Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Heartworm Disease Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Heartworm Disease Treatment Market Size (2018-2029)
9.2 Latin America Heartworm Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Heartworm Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Heartworm Disease Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Heartworm Disease Treatment Market Size (2018-2029)
10.2 Middle East & Africa Heartworm Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Heartworm Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Heartworm Disease Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Heartworm Disease Treatment Introduction
11.1.4 Boehringer Ingelheim Revenue in Heartworm Disease Treatment Business (2018-2023)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Wellmark International, Inc
11.2.1 Wellmark International, Inc Company Detail
11.2.2 Wellmark International, Inc Business Overview
11.2.3 Wellmark International, Inc Heartworm Disease Treatment Introduction
11.2.4 Wellmark International, Inc Revenue in Heartworm Disease Treatment Business (2018-2023)
11.2.5 Wellmark International, Inc Recent Development
11.3 HEARTGARD Plus
11.3.1 HEARTGARD Plus Company Detail
11.3.2 HEARTGARD Plus Business Overview
11.3.3 HEARTGARD Plus Heartworm Disease Treatment Introduction
11.3.4 HEARTGARD Plus Revenue in Heartworm Disease Treatment Business (2018-2023)
11.3.5 HEARTGARD Plus Recent Development
11.4 Merck Animal Health (Merck & Co., Inc.)
11.4.1 Merck Animal Health (Merck & Co., Inc.) Company Detail
11.4.2 Merck Animal Health (Merck & Co., Inc.) Business Overview
11.4.3 Merck Animal Health (Merck & Co., Inc.) Heartworm Disease Treatment Introduction
11.4.4 Merck Animal Health (Merck & Co., Inc.) Revenue in Heartworm Disease Treatment Business (2018-2023)
11.4.5 Merck Animal Health (Merck & Co., Inc.) Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Detail
11.5.2 Pfizer Inc Business Overview
11.5.3 Pfizer Inc Heartworm Disease Treatment Introduction
11.5.4 Pfizer Inc Revenue in Heartworm Disease Treatment Business (2018-2023)
11.5.5 Pfizer Inc Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Detail
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Heartworm Disease Treatment Introduction
11.6.4 Bayer AG Revenue in Heartworm Disease Treatment Business (2018-2023)
11.6.5 Bayer AG Recent Development
11.7 Mylan N.V
11.7.1 Mylan N.V Company Detail
11.7.2 Mylan N.V Business Overview
11.7.3 Mylan N.V Heartworm Disease Treatment Introduction
11.7.4 Mylan N.V Revenue in Heartworm Disease Treatment Business (2018-2023)
11.7.5 Mylan N.V Recent Development
11.8 Ceva Sante Animale S.A
11.8.1 Ceva Sante Animale S.A Company Detail
11.8.2 Ceva Sante Animale S.A Business Overview
11.8.3 Ceva Sante Animale S.A Heartworm Disease Treatment Introduction
11.8.4 Ceva Sante Animale S.A Revenue in Heartworm Disease Treatment Business (2018-2023)
11.8.5 Ceva Sante Animale S.A Recent Development
11.9 PetCareRx
11.9.1 PetCareRx Company Detail
11.9.2 PetCareRx Business Overview
11.9.3 PetCareRx Heartworm Disease Treatment Introduction
11.9.4 PetCareRx Revenue in Heartworm Disease Treatment Business (2018-2023)
11.9.5 PetCareRx Recent Development
11.10 Ecto Development Corporation
11.10.1 Ecto Development Corporation Company Detail
11.10.2 Ecto Development Corporation Business Overview
11.10.3 Ecto Development Corporation Heartworm Disease Treatment Introduction
11.10.4 Ecto Development Corporation Revenue in Heartworm Disease Treatment Business (2018-2023)
11.10.5 Ecto Development Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
